Leslie Lynne Sharp

Title: The Innovative Contributions of Leslie Lynne Sharp

Introduction

Leslie Lynne Sharp is a prominent inventor based in Rancho Santa Fe, CA (US). She has made significant strides in the field of biotechnology, particularly in cancer treatment. With a total of 2 patents to her name, her work focuses on utilizing oncolytic viruses to combat various forms of cancer.

Latest Patents

One of her latest patents involves an oncolytic virus platform designed to treat cancers using the myxoma virus. This patent discloses recombinant myxoma viruses (MYXVs) and nucleic acid constructs that encode these viruses. In certain embodiments, the MYXVs are engineered to inactivate or attenuate the activity or expression level of an M153 protein. Additionally, the MYXVs can express transgenes such as tumor necrosis factor (TNF), interleukin-12 (IL-12), or decorin. The patent also outlines methods for using these MYXVs, including providing them to subjects in need of treatment.

Career Highlights

Leslie has worked with notable institutions, including Arizona State University and Oncomyx Therapeutics, Inc. Her contributions to the field have been recognized for their potential impact on cancer therapies.

Collaborations

Throughout her career, Leslie has collaborated with esteemed colleagues such as Douglas Grant McFadden and Mohammed Masmudur Rahman. These partnerships have furthered her research and development efforts in innovative cancer treatments.

Conclusion

Leslie Lynne Sharp's work exemplifies the intersection of innovation and healthcare. Her patents and collaborations highlight her commitment to advancing cancer treatment through groundbreaking research.